SEC Form 4/A · accession 0001615774-18-013077
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michal Votruba
Director
Period of report
Oct 8, 2018
Accepted (ET)
Nov 20, 2018 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Oct 8, 2018 | A | 144,000 | $1.38 | A | 144,000 | D | |
| COMMON STOCKF1 | Oct 8, 2018 | D | 144,000 | $1.38 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On October 8, 2018, the Reporting Person was granted 144,000 shares of restricted common stock under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. The Reporting Person immediately and automatically assigned all benefits resulting from the October 8, 2018 grant of restricted common stock to RSJ Investments SICAV a.s. ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of MYnd Analytics, Inc. at the request of RSJ.